Personal information

Activities

Employment (2)

University of Helsinki: Helsinki, FI

Employment
Source: check_circle
University of Helsinki

Helsinki University Hospital: Helsinki, FI

Employment
Source: Self-asserted source
Maarit Ahava

Education and qualifications (2)

University of Helsinki: Helsinki, FI

Education
Source: check_circle
University of Helsinki

Tampere University: Tampere, FI

2010-08-16 to 2017-03-30 | Medical doctor (Faculty of Medicine and Health Technology)
Education
Source: Self-asserted source
Maarit Ahava

Professional activities (1)

European Society of Clinical Microbiology and Infectious Diseases: Basel, CH

Young scientist member
Membership
Source: Self-asserted source
Maarit Ahava

Works (17)

Impact of selective reporting of wound cultures on microbiology reports and antimicrobial-drug use on a wound-care ward in Finland

EBioMedicine
2024-02 | Journal article | Author
SOURCE-WORK-ID:

ed7224d5-30ca-4194-a48f-142e414fafd0

EID:

2-s2.0-85184063123

WOSUID:

001178402000001

Contributors: Jukka A. Torvikoski; Laura K. Lehtola; Maarit Ahava; Laura M. Pakarinen; Päivi J. Tissari; Anu Sylvia Pätäri-Sampo
Source: check_circle
University of Helsinki

Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report

Infectious Diseases
2023-08-03 | Journal article
Contributors: Anna L. Lindahl; Maarit J. Ahava; Mia Haukipää; Hanna-Riikka Kreivi; Anne Lipponen; Elisa Kortela
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Shiga toxin‐producing Escherichia coli (STEC) stool multiplex PCR can replace culture for clinical diagnosis and follow‐up

APMIS
2023-07 | Journal article
Contributors: Anu E. Jääskeläinen; Saara Salmenlinna; Jenni Antikainen; Reetta Sihvonen; Maarit Ahava; Eveliina Tarkka; Anu Pätäri‐Sampo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Low incidence of severe bacterial infections in hospitalised patients with COVID-19: A population-based registry study

Infectious Diseases
2023-02-01 | Journal article
Contributors: M. J. Ahava; E. Kortela; E. Forsblom; A. Pätäri-Sampo; N. Friberg; A. Meretoja; S.-M. Kivivuori; M. Lappalainen; S. Kurkela; A. Järvinen et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clinical microbiology in the time of COVID-19 : Evaluation and application of SARS-CoV-2 laboratory diagnostics

2022 | Dissertation or Thesis | Author
SOURCE-WORK-ID:

6bc26e25-ff8c-4859-a3e9-d605ae0f60b6

Contributors: Maarit Ahava
Source: check_circle
University of Helsinki

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland

European Journal of Clinical Microbiology & Infectious Diseases
2022-06 | Journal article | Author
SOURCE-WORK-ID:

34174d9d-4eb3-4666-8ea3-4377260e9931

WOSUID:

000788499600001

Contributors: Maarit Ahava; Hanna Kirsti Jarva; Anne J. Jääskeläinen; Maija Leena Lappalainen; Olli Pekka Vapalahti; Satu Kurkela
Source: check_circle
University of Helsinki

The phylodynamics of SARS-CoV-2 during 2020 in Finland

Communication Medicine
2022-06-10 | Journal article | Author
SOURCE-WORK-ID:

546f1781-4ec6-4847-828a-83f11e3dc055

WOSUID:

001023081100028

Contributors: Phuoc Truong Nguyen; Ravi Kant; Frederik Van den Broeck; Maija Suvanto; Hussein Alburkat; Jenni Virtanen; Ella Ahvenainen; Robert Castren; Samuel L. Hong; Guy Baele et al.
Source: check_circle
University of Helsinki

Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection

Journal of Virological Methods
2022-04 | Journal article
Contributors: M.J. Ahava; S. Kurkela; S. Kuivanen; M. Lappalainen; H. Jarva; A.J. Jääskeläinen
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland

2022-03-30 | Preprint
Contributors: MJ Ahava; H Jarva; AJ Jääskeläinen; M Lappalainen; O Vapalahti; S Kurkela
Source: check_circle
Crossref

Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area – a population-based registry study

Infectious Diseases
2021-10-03 | Journal article
Contributors: Erik Forsblom; Suvi Silén; Elisa Kortela; Maarit Ahava; Hanna-Riikka Kreivi; Ville Holmberg; Asko Järvinen; Johanna Hästbacka; Sanna-Maria Kivivuori; Atte Meretoja
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

PLoS One
2021-05-21 | Journal article | Author
SOURCE-WORK-ID:

23c50057-7622-45cf-af91-c6e598a63844

WOSUID:

000664632300029

Contributors: Elisa Kortela; Vesa Kirjavainen; Maarit Ahava; Suvi T Jokiranta; Anna But; Anna L Lindahl; Anu E. Jääskeläinen; Annemarjut J. Jääskeläinen; Asko Järvinen; Pia Jokela et al.
Source: check_circle
University of Helsinki

A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection—SARS-CoV-2 as a Proof of Concept

mBio
2021-05-18 | Journal article | Author
SOURCE-WORK-ID:

2fff13d6-7c08-4841-9ca1-98abff1e8ea9

WOSUID:

000694797200015

Contributors: Juuso Rusanen; Lauri Kareinen; Leonora Szirovicza; Hasan Uğurlu; Lev Levanov; Anu Jääskeläinen; Maarit Ahava; Satu Kurkela; Kalle Martti Saksela; Klaus Hedman et al.
Source: check_circle
University of Helsinki

Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection

Journal of Clinical Virology
2021-04 | Journal article
Contributors: A.E. Jääskeläinen; M.J. Ahava; P. Jokela; L. Szirovicza; S. Pohjala; O. Vapalahti; M. Lappalainen; J. Hepojoki; S. Kurkela
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection

2021-01-13 | Other
Contributors: MJ Ahava; S Kurkela; S Kuivanen; M Lappalainen; H Jarva; AJ Jääskeläinen
Source: check_circle
Crossref

Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection

2021-01-04 | Other
Contributors: AE Jääskeläinen; MJ Ahava; P Jokela; L Szirovicza; S Pohjala; O Vapalahti; M Lappalainen; J Hepojoki; S Kurkela
Source: check_circle
Crossref

SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department

Journal of Clinical Virology
2020-10 | Journal article | Author
SOURCE-WORK-ID:

ab70ba23-0296-4252-87e9-3f2cac624179

WOSUID:

000571894100008

Contributors: Pia Jokela; Anu E. Jääskeläinen; Hanna Kirsti Jarva; Tanja Holma; Maarit Ahava; Laura Mannonen; Maija Leena Lappalainen; Satu Kurkela; Raisa Loginov
Source: check_circle
University of Helsinki

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

Journal of Clinical Virology
2020-08 | Journal article | Author
SOURCE-WORK-ID:

92a40e00-6652-45a2-ab2e-f653eaf0a389

WOSUID:

000552972500026

Contributors: A. J. Jaaskelainen; S. Kuivanen; Eliisa Laura Johanna Kekäläinen; Maarit Ahava; R. Loginov; H. Kallio-Kokko; Olli Pekka Vapalahti; Hanna Kirsti Jarva; Satu Kurkela; Maija Leena Lappalainen
Source: check_circle
University of Helsinki